Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens.

Identifieur interne : 001286 ( PubMed/Corpus ); précédent : 001285; suivant : 001287

Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens.

Auteurs : Rashmi Dixit ; Jenny Herz ; Richard Dalton ; Robert Booy

Source :

RBID : pubmed:26802604

English descriptors

Abstract

Passive immunotherapy using polyclonal antibodies (immunoglobulins) has been used for over a century in the treatment and post-exposure prophylaxis of various infections and toxins. Heterologous polyclonal antibodies are obtained from animals hyperimmunised with a pathogen or toxin.

DOI: 10.1016/j.vaccine.2016.01.016
PubMed: 26802604

Links to Exploration step

pubmed:26802604

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens.</title>
<author>
<name sortKey="Dixit, Rashmi" sort="Dixit, Rashmi" uniqKey="Dixit R" first="Rashmi" last="Dixit">Rashmi Dixit</name>
<affiliation>
<nlm:affiliation>The Children's Hospital, Westmead, Sydney, Australia. Electronic address: rushmi7@gmail.com.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Herz, Jenny" sort="Herz, Jenny" uniqKey="Herz J" first="Jenny" last="Herz">Jenny Herz</name>
<affiliation>
<nlm:affiliation>Biointelect, Sydney, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dalton, Richard" sort="Dalton, Richard" uniqKey="Dalton R" first="Richard" last="Dalton">Richard Dalton</name>
<affiliation>
<nlm:affiliation>University of Southampton, Southampton, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Booy, Robert" sort="Booy, Robert" uniqKey="Booy R" first="Robert" last="Booy">Robert Booy</name>
<affiliation>
<nlm:affiliation>The Children's Hospital, Westmead, Sydney, Australia.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26802604</idno>
<idno type="pmid">26802604</idno>
<idno type="doi">10.1016/j.vaccine.2016.01.016</idno>
<idno type="wicri:Area/PubMed/Corpus">001286</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001286</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens.</title>
<author>
<name sortKey="Dixit, Rashmi" sort="Dixit, Rashmi" uniqKey="Dixit R" first="Rashmi" last="Dixit">Rashmi Dixit</name>
<affiliation>
<nlm:affiliation>The Children's Hospital, Westmead, Sydney, Australia. Electronic address: rushmi7@gmail.com.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Herz, Jenny" sort="Herz, Jenny" uniqKey="Herz J" first="Jenny" last="Herz">Jenny Herz</name>
<affiliation>
<nlm:affiliation>Biointelect, Sydney, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Dalton, Richard" sort="Dalton, Richard" uniqKey="Dalton R" first="Richard" last="Dalton">Richard Dalton</name>
<affiliation>
<nlm:affiliation>University of Southampton, Southampton, United Kingdom.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Booy, Robert" sort="Booy, Robert" uniqKey="Booy R" first="Robert" last="Booy">Robert Booy</name>
<affiliation>
<nlm:affiliation>The Children's Hospital, Westmead, Sydney, Australia.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Vaccine</title>
<idno type="eISSN">1873-2518</idno>
<imprint>
<date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Anaphylaxis (prevention & control)</term>
<term>Animals</term>
<term>Antibodies (chemistry)</term>
<term>Antibodies (therapeutic use)</term>
<term>Antitoxins (therapeutic use)</term>
<term>Antivenins (therapeutic use)</term>
<term>Clinical Trials as Topic</term>
<term>Communicable Diseases (therapy)</term>
<term>History, 19th Century</term>
<term>History, 20th Century</term>
<term>History, 21st Century</term>
<term>Humans</term>
<term>Immunization, Passive (history)</term>
<term>Post-Exposure Prophylaxis</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Antibodies</term>
</keywords>
<keywords scheme="MESH" qualifier="history" xml:lang="en">
<term>Immunization, Passive</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Anaphylaxis</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antibodies</term>
<term>Antitoxins</term>
<term>Antivenins</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Communicable Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Clinical Trials as Topic</term>
<term>History, 19th Century</term>
<term>History, 20th Century</term>
<term>History, 21st Century</term>
<term>Humans</term>
<term>Post-Exposure Prophylaxis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Passive immunotherapy using polyclonal antibodies (immunoglobulins) has been used for over a century in the treatment and post-exposure prophylaxis of various infections and toxins. Heterologous polyclonal antibodies are obtained from animals hyperimmunised with a pathogen or toxin.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">26802604</PMID>
<DateCompleted>
<Year>2016</Year>
<Month>09</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1873-2518</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>34</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2016</Year>
<Month>Feb</Month>
<Day>24</Day>
</PubDate>
</JournalIssue>
<Title>Vaccine</Title>
<ISOAbbreviation>Vaccine</ISOAbbreviation>
</Journal>
<ArticleTitle>Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens.</ArticleTitle>
<Pagination>
<MedlinePgn>1152-61</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2016.01.016</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0264-410X(16)00042-6</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Passive immunotherapy using polyclonal antibodies (immunoglobulins) has been used for over a century in the treatment and post-exposure prophylaxis of various infections and toxins. Heterologous polyclonal antibodies are obtained from animals hyperimmunised with a pathogen or toxin.</AbstractText>
<AbstractText Label="AIMS" NlmCategory="OBJECTIVE">The aims of this review are to examine the history of animal polyclonal antibody therapy use, their development into safe and effective products and the potential application to humans for emerging and neglected infectious diseases.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A literature search of OVID Medline and OVID Embase databases was undertaken to identify articles on the safety, efficacy and ongoing development of polyclonal antibodies. The search contained database-specific MeSH and EMTREE terms in combination with pertinent text-words: polyclonal antibodies and rare/neglected diseases, antivenins, immunoglobulins, serum sickness, anaphylaxis, drug safety, post marketing surveillance, rabies, human influenza, Dengue, West Nile, Nipah, Hendra, Marburg, MERS, Hemorrhagic Fever Virus, and Crimean-Congo. No language limits were applied. The final search was completed on 20.06.2015. Of 1960 articles, title searches excluded many irrelevant articles, yielding 303 articles read in full. Of these, 179 are referenced in this study.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Serum therapy was first used in the 1890s against diphtheria. Early preparation techniques yielded products contaminated with reactogenic animal proteins. The introduction of enzymatic digestion, and purification techniques substantially improved their safety profile. The removal of the Fc fragment of antibodies further reduces hypersensitivity reactions. Clinical studies have demonstrated the efficacy of polyclonal antibodies against various infections, toxins and venoms. Products are being developed against infections for which prophylactic and therapeutic options are currently limited, such as avian influenza, Ebola and other zoonotic viruses.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Polyclonal antibodies have been successfully applied to rabies, envenomation and intoxication. Polyclonal production provides an exciting opportunity to revolutionise the prognosis of both longstanding neglected tropical diseases as well as emerging infectious threats to humans.</AbstractText>
<CopyrightInformation>Crown Copyright © 2016. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dixit</LastName>
<ForeName>Rashmi</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>The Children's Hospital, Westmead, Sydney, Australia. Electronic address: rushmi7@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Herz</LastName>
<ForeName>Jenny</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Biointelect, Sydney, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Dalton</LastName>
<ForeName>Richard</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>University of Southampton, Southampton, United Kingdom.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Booy</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>The Children's Hospital, Westmead, Sydney, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016456">Historical Article</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2016</Year>
<Month>01</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Vaccine</MedlineTA>
<NlmUniqueID>8406899</NlmUniqueID>
<ISSNLinking>0264-410X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000906">Antibodies</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000992">Antitoxins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000997">Antivenins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000707" MajorTopicYN="N">Anaphylaxis</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000906" MajorTopicYN="N">Antibodies</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000992" MajorTopicYN="N">Antitoxins</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000997" MajorTopicYN="N">Antivenins</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003141" MajorTopicYN="N">Communicable Diseases</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D049672" MajorTopicYN="N">History, 19th Century</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D049674" MajorTopicYN="N">History, 21st Century</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007116" MajorTopicYN="N">Immunization, Passive</DescriptorName>
<QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D056990" MajorTopicYN="N">Post-Exposure Prophylaxis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Antitoxin</Keyword>
<Keyword MajorTopicYN="N">Antivenin</Keyword>
<Keyword MajorTopicYN="N">Arboviruses</Keyword>
<Keyword MajorTopicYN="N">Immunotherapy</Keyword>
<Keyword MajorTopicYN="N">Influenza</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2015</Year>
<Month>09</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2016</Year>
<Month>01</Month>
<Day>06</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2016</Year>
<Month>01</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2016</Year>
<Month>1</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2016</Year>
<Month>1</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>9</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26802604</ArticleId>
<ArticleId IdType="pii">S0264-410X(16)00042-6</ArticleId>
<ArticleId IdType="doi">10.1016/j.vaccine.2016.01.016</ArticleId>
<ArticleId IdType="pmc">PMC7131169</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Acad Emerg Med. 2012 Feb;19(2):121-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22320362</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Hum Immunol. 2004 Jun;65(6):578-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15219377</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 1999 Feb;179 Suppl 1:S218-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9988187</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Rev Inst Med Trop Sao Paulo. 1994 Sep-Oct;36(5):451-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7569613</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 1999 Jun;37(6):895-908</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10340829</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biologicals. 2012 Mar;40(2):129-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22266304</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 1997 Mar;35(3):411-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9080596</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Med. 2007 May;4(5):e178</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17535101</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 2001 Jun;39(6):793-801</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11137538</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>West J Med. 2001 Aug;175(2):88-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11483547</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Infect Disord Drug Targets. 2013 Feb;13(1):34-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23675925</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2013 Dec 14;382(9909):1993-2002</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24055451</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Emerg Med. 2013 Apr;61(4):458-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23380292</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Influenza Other Respir Viruses. 2011 May;5(Suppl 1):226-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21761590</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Emerg Med. 1983 Jul;1(1):83-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6680610</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Med J Aust. 2008 Apr 21;188(8):473-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18429716</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 1998 Jun;36(6):823-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9663690</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biologicals. 2004 Sep;32(3):115-28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15536042</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Wilderness Environ Med. 2003 Winter;14(4):220-1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14719854</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2009 May 14;360(20):2090-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19439743</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 2004 Dec 1;44(7):731-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15500849</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):5034-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22411795</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Venom Anim Toxins Incl Trop Dis. 2015 Feb 15;21:3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25705218</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 2004 Jul;44(1):53-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15225562</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2008 Apr 26;371(9622):1427-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18400288</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Surg. 1991 May;213(5):466-71; discussion 471-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2025067</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Coll Antropol. 2011 Mar;35(1):249-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21667541</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Bull World Health Organ. 1989;67(6):731-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2633888</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMJ. 2013 Aug 06;347:f4752</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23920350</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Med J Aust. 2005 Apr 18;182(8):407-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15850438</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Infect Dis Clin North Am. 2011 Dec;25(4):789-802</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22054756</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 1995 Mar 9;332(10):642-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7845428</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trans R Soc Trop Med Hyg. 2007 Feb;101(2):206-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16806332</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vopr Virusol. 1995 Nov-Dec;40(6):270-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8686265</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Trauma. 1988 Jul;28(7):1032-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2899649</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Emerg Med. 2001 Feb;37(2):181-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11174237</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Int Immunopharmacol. 2007 Mar;7(3):392-400</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17276898</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Respir Med. 2013 Dec;1(10):771-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24461756</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Negl Trop Dis. 2010 Jul 27;4(7):e767</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20668549</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMJ. 2004 Nov 13;329(7475):1129</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15539665</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Acta Virol. 2011;55(3):261-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21978160</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Viral Immunol. 2007 Spring;20(1):197-205</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17425434</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 2007 May;49(6):780-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17210167</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Biotechnol. 2011 Sep;28(5):489-501</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21473942</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trans R Soc Trop Med Hyg. 1998 Nov-Dec;92(6):657-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10326114</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Anaesth Intensive Care. 2009 Jul;37(4):613-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19681421</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trans R Soc Trop Med Hyg. 2001 Jan-Feb;95(1):74-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11280073</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Circulation. 1990 Jun;81(6):1744-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2188752</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Toxicol (Phila). 2012 Jan;50(1):70-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22175789</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Mar 15;848(1):2-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16893686</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 2011 Dec 1;58(8):634-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21967812</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Am Coll Cardiol. 1991 Mar 1;17(3):590-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1993775</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Microbiol. 2004 Sep;2(9):695-703</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15372080</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Med J Aust. 2006 Apr 17;184(8):419-20.</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16618245</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>QJM. 2009 Aug;102(8):563-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19570990</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Hong Kong Med J. 2006 Dec;12(6):489</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17148811</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Immunotherapy. 2014;6(6):699-708</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24673720</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2001 May;75(10):4649-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11312335</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2013 Sep 27;62(38):793-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24067584</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Med J Aust. 2013 Mar 4;198(4):194-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23451958</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Med J. 2008 Dec;25(12):793-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19033492</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 1969 Jun;7(1):25-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">5804762</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Acta Trop. 2008 Feb;105(2):203-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17996842</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2010 Oct 26;5(10):e13622</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21049034</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Toxicol Clin Toxicol. 2003;41(7):937-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14705838</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Emerg Med. 2011 Feb;57(2):128-137.e3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20952098</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Viral Immunol. 2007 Sep;20(3):495-502</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17931120</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Arch Intern Med. 2001 Sep 10;161(16):2030-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11525706</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Toxicol (Phila). 2015 Jan;53(1):37-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25361165</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Commun Dis. 2011 Mar;43(1):31-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23785880</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2013 Jun 29;381(9885):2265-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23727167</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Surg. 2006 Dec;192(6):848-52</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17161106</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 2010 Oct 15;202(8):1154-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20831384</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Emerg Med. 1992 Jul;21(7):782-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1351707</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Emerg Med. 2008 Apr;51(4):407-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18191286</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 1987 Nov 28;2(8570):1275</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2890885</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Cochrane Database Syst Rev. 2000;(2):CD002153</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10796682</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Intern Med. 2006 Oct 17;145(8):599-609</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16940336</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Dis. 1999 Feb;179 Suppl 1:S224-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9988188</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 2005 Dec 1;46(7):797-805</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16197974</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 2009 Dec 1;54(7):998-1011</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19591857</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Int J Clin Pract. 2000 Jun;54(5):322-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10954960</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2013 Dec 14;382(9909):1962-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24055454</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Pharmacokinet. 2003;42(8):721-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12846594</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicol Appl Pharmacol. 1996 Nov;141(1):272-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8917700</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Negl Trop Dis. 2008 May 28;2(5):e243</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18509475</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Trop Med Hyg. 2007 Sep;77(3):538-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17827375</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Pharmacother. 2011 Dec;45(12):1491-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22116992</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 2003 Apr;41(5):541-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12676433</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>CA Cancer J Clin. 1976 Mar-Apr;26(2):119-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">816431</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Br Med J (Clin Res Ed). 1986 Jan 4;292(6512):17-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3080048</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>S Afr Med J. 2009 Nov;99(11):814-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20218483</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 2007 Jan;49(1):57-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17055016</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2006 Oct;12(10):1203-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16964257</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Scand J Surg. 2003;92(2):171-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12841560</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMJ. 2011 Jan 05;342:c7136</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21209062</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biologicals. 2011 May;39(3):129-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21429763</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Emerg Med. 1991 Jul;20(7):795-801</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2064103</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2015 Jun;89(11):6117-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25787284</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Intensive Care Med. 2009 Sep;35(9):1532-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19547954</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Intern Med. 1997 Jan;241(1):53-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9042094</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 1976 Apr 8;294(15):797-800</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">943040</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Acad Emerg Med. 2001 Feb;8(2):177-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11157295</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Mil Med. 2003 Mar;168(3):246-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12685693</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Assoc Physicians India. 2006 Apr;54:283-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16944610</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Presse Med. 1999 Nov 13;28(35):1929-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10598149</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Infect Dis. 2015 Mar;15(3):285-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25662592</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trans R Soc Trop Med Hyg. 2006 Dec;100(12):1173-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16698053</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Arch Virol Suppl. 1996;11:135-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8800795</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Indian Pediatr. 2014 Feb;51(2):131-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24277969</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Toxicol Clin Toxicol. 2003;41(3):309-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12807314</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 1994 Apr;32(4):427-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8052997</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 2010 Dec 15;56(7):1223-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19951718</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 2006 Dec 1;48(7):738-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17030053</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 1985;23(3):409-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3927522</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2004 Jan;78(2):834-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14694115</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Med J Aust. 1989 Jun 19;150(12):698-702</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2733617</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Med Clin North Am. 2004 May;22(2):423-43, ix</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15163575</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Clin Toxicol (Phila). 2012 Mar;50(3):189-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22372786</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biologicals. 2002 Jun;30(2):143-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12127316</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Emerg Med. 2002 Jun;39(6):609-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12023703</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxins (Basel). 2014 Jan 21;6(1):380-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24451844</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 2012 Jan;59(1):86-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22056768</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS Curr. 2014 Nov 24;6:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25685624</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vaccine. 2009 Nov 27;27(51):7162-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19925947</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Int J Antimicrob Agents. 2003 Feb;21(2):170-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12615382</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BioDrugs. 2011 Apr 1;25(2):69-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21443271</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Med J. 2011 Nov;28(11):963-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21561982</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2007 Oct 4;357(14):1450-1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17914053</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Emerg Med. 2002 Jun;39(6):671-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12023714</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2012;7(6):e38739</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22719932</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2012;7(4):e35996</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22558299</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Toxicon. 2012 Feb;59(2):344-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22146491</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Curr Opin Biotechnol. 2009 Dec;20(6):668-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19896824</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Bull Soc Pathol Exot. 2012 Aug;105(3):157-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22359185</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Intern Med J. 2007 Dec;37(12):820-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18028082</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2014 Feb 28;9(2):e89674</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24586955</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Emerg Med. 2006 Apr;47(4):398-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16546632</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Med J Aust. 2010 Dec 6-20;193(11-12):696-700</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21143062</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMC Emerg Med. 2009 Jun 22;9:13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19545426</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Int Immunopharmacol. 2011 Dec;11(12):2000-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21906698</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Toxicol. 2010 Dec;6(4):393-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20358414</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Pharmacol Exp Ther. 1997 Apr;281(1):1-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9103473</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Acad Emerg Med. 2007 Apr;14(4):373-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17296804</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Trop Med Hyg. 1997 Mar;56(3):291-300</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9129531</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 1996 Feb 10;347(8998):406</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8598738</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Pharmacotherapy. 2012 May;32(5):433-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22467377</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Ann Emerg Med. 1997 Jul;30(1):33-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9209222</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Trop Med Hyg. 1999 Dec;61(6):1017-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10674688</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2005 Jan 27;352(4):333-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15668219</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vopr Virusol. 1994 Mar-Apr;39(2):82-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8017061</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect. 2014 Mar;68(3):205-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24406432</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Pediatr Surg. 2008 Jul;43(7):1338-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18639692</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001286 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001286 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:26802604
   |texte=   Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:26802604" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021